TrialEMBO molecular medicine2018
The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease.
Ulf Neumann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
82 papers cite itlatest 60 shown
this papertrialcites it
TrialEMBO molecular medicine2018
Ulf Neumann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.